Marks Group Wealth Management Inc Has $14.43 Million Stake in UnitedHealth Group Incorporated (NYSE:UNH)

Marks Group Wealth Management Inc boosted its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 2.2% in the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 27,403 shares of the healthcare conglomerate’s stock after purchasing an additional 598 shares during the quarter. UnitedHealth Group comprises 1.6% of Marks Group Wealth Management Inc’s portfolio, making the stock its 5th largest holding. Marks Group Wealth Management Inc’s holdings in UnitedHealth Group were worth $14,427,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also recently added to or reduced their stakes in UNH. International Assets Investment Management LLC lifted its holdings in shares of UnitedHealth Group by 9.5% during the third quarter. International Assets Investment Management LLC now owns 4,383 shares of the healthcare conglomerate’s stock worth $2,208,000 after buying an additional 379 shares during the last quarter. Caliber Wealth Management LLC raised its stake in shares of UnitedHealth Group by 3.3% in the third quarter. Caliber Wealth Management LLC now owns 5,060 shares of the healthcare conglomerate’s stock valued at $2,551,000 after purchasing an additional 161 shares in the last quarter. Buckingham Capital Management Inc. raised its stake in shares of UnitedHealth Group by 1.4% in the third quarter. Buckingham Capital Management Inc. now owns 25,277 shares of the healthcare conglomerate’s stock valued at $12,744,000 after purchasing an additional 361 shares in the last quarter. Cooper Financial Group raised its stake in shares of UnitedHealth Group by 6.5% in the third quarter. Cooper Financial Group now owns 2,042 shares of the healthcare conglomerate’s stock valued at $1,030,000 after purchasing an additional 125 shares in the last quarter. Finally, Scharf Investments LLC raised its stake in shares of UnitedHealth Group by 0.8% in the third quarter. Scharf Investments LLC now owns 3,349 shares of the healthcare conglomerate’s stock valued at $1,689,000 after purchasing an additional 28 shares in the last quarter. Institutional investors own 87.86% of the company’s stock.

Insider Buying and Selling at UnitedHealth Group

In other UnitedHealth Group news, CAO Thomas E. Roos sold 858 shares of the stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the transaction, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other news, CAO Thomas E. Roos sold 858 shares of the firm’s stock in a transaction dated Friday, February 23rd. The stock was sold at an average price of $525.79, for a total transaction of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at $16,977,233.31. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Also, EVP Erin Mcsweeney sold 1,236 shares of the firm’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the sale, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. Insiders own 0.35% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of recent research reports. Oppenheimer restated an “outperform” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research note on Wednesday, January 17th. Barclays upped their price target on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research report on Wednesday, April 17th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $591.00 price target on shares of UnitedHealth Group in a research report on Wednesday, April 10th. Deutsche Bank Aktiengesellschaft upped their price target on UnitedHealth Group from $545.00 to $562.00 and gave the company a “buy” rating in a research report on Friday. Finally, Morgan Stanley lowered their price target on UnitedHealth Group from $618.00 to $584.00 and set an “overweight” rating on the stock in a research report on Friday, April 5th. Four equities research analysts have rated the stock with a hold rating and fifteen have assigned a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $570.05.

UnitedHealth Group Trading Down 2.0 %

UnitedHealth Group stock traded down $9.90 during mid-day trading on Monday, hitting $491.23. The stock had a trading volume of 4,691,233 shares, compared to its average volume of 4,554,929. The stock has a 50-day simple moving average of $488.10 and a two-hundred day simple moving average of $515.03. The stock has a market capitalization of $452.88 billion, a PE ratio of 30.03, a P/E/G ratio of 1.38 and a beta of 0.54. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $554.70. The company has a current ratio of 0.85, a quick ratio of 0.79 and a debt-to-equity ratio of 0.69.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.63 by $0.28. The business had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm’s quarterly revenue was up 8.6% compared to the same quarter last year. During the same quarter last year, the business earned $6.26 earnings per share. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 27.61 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a $1.88 dividend. This represents a $7.52 annualized dividend and a yield of 1.53%. The ex-dividend date of this dividend was Friday, March 8th. UnitedHealth Group’s payout ratio is 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.